Comparison of triple-lumen central venous catheters impregnated with silver nanoparticles (AgTive®) vs conventional catheters in intensive care unit patients

Journal of Hospital Infection

Volumn 82, Issue 2, 2012, Pages 101-107

  Antonelli, M ^a   De Pascale, G ^a   Ranieri, V M ^b   Pelaia, P ^c   Tufano, R ^d   Piazza, O ^d   Zangrillo, A ^e   Ferrario, A ^f   De Gaetano, A ^g   Guaglianone, E ^h   Donelli, G ^h  

^a CATHOLIC UNIVERSITY   (Italy)

^b MOLINETTE HOSPITAL   (Italy)

^c UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^d UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^e VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^f Ferrario Dati sas   (Italy)

^g CNR   (Italy)

^h IRCCS FONDAZIONE SANTA LUCIA   (Italy)

Author keywords

Bloodstream infection; Central venous catheter; Prevention of infection; Silver nanoparticles

Indexed keywords

SILVER NANOPARTICLE;

ADULT; AGED; ARTICLE; CATHETER INFECTION; CENTRAL VENOUS CATHETER; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; FEMALE; HUMAN; INTENSIVE CARE; MAJOR CLINICAL STUDY; MALE; MICROBIAL COLONIZATION; MORTALITY; OUTCOME ASSESSMENT; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SILVER NANOPARTICLE IMPREGNATED CENTRAL VENOUS CATHETER;

ADULT; AGED; AGED, 80 AND OVER; ANTI-INFECTIVE AGENTS; CATHETER-RELATED INFECTIONS; CENTRAL VENOUS CATHETERS; FEMALE; HUMANS; INCIDENCE; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; NANOPARTICLES; PROSPECTIVE STUDIES; SILVER; SURVIVAL ANALYSIS;

EID: 84866355853     PISSN: 01956701     EISSN: 15322939     Source Type: Journal    
DOI: 10.1016/j.jhin.2012.07.010     Document Type: Article

References (36)

1. Maki D.G., Kluger D.M., Crnich C.J. The risk of bloodstream infection in adults with different intravascular devices: a systematic review of 200 published retrospective studies. Mayo Clin Proc 2006, 8:1159-1171.
2. Pittet D., Tarara D., Wenzel R.P. Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality. JAMA 1994, 271:1598-1601.
3. Mermel L. Infections related to central venous catheters in US intensive-care units. Lancet 2003, 361:1562.
4. Mermel L.A. Prevention of intravascular catheter-related infections. Ann Intern Med 2000, 132:391-402.
5. O'Grady N.P., Alexander M., Dellinger E.P., et al. Guidelines for the prevention of intravascular catheter-related infections. Infect Control Hosp Epidemiol 2002, 23:759-769.
6. Mermel L.A., Allon M., Bouza E., et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 2009, 49:1-45.
7. O'Grady N.P., Alexander M., Burns L.A., et al. Guidelines for the prevention of intravascular catheter-related infections. Am J Infect Control 2011, 39(Suppl. 1):S1-34.
8. Eggimann P. Prevention of intravascular catheter infection. Curr Opin Infect Dis 2007, 20:360-369.
9. Brun-Buisson C., Doyon F., Sollet J.P., Cochard J.F., Cohen Y., Nitenberg G. Prevention of intravascular catheter-related infection with newer chlorhexidine-silver sulfadiazine-coated catheters: a randomized controlled trial. Intens Care Med 2004, 30:837-843.
10. Carrasco M.N., Bueno A., de las Cuevas C., et al. Evaluation of a triple-lumen central venous heparin-coated catheter versus a catheter coated with chlorhexidine and silver sulfadiazine in critically ill patients. Intens Care Med 2004, 30:633-638.
11. Hagau N., Studnicska D., Gavrus R.L., Csipak G., Hagau R., Slavcovici A.V. Central venous catheter colonization and catheter-related bloodstream infections in critically ill patients: a comparison between standard and silver-integrated catheters. Eur J Anaesthesiol 2009, 26:752-758.
12. Walz J.M., Avelar R.L., Longtine K.J., Carter K.L., Mermel L.A., Heard S.O. Anti-infective external coating of central venous catheters: a randomized, non-inferiority trial comparing 5-fluorouracil with chlorhexidine/silver sulfadiazine in preventing catheter colonization. Crit Care Med 2010, 38:2095-2102.
13. Casey A.L., Mermel L.A., Nightingale P., Elliott T.S. Antimicrobial central venous catheters in adults: a systematic review and meta-analysis. Lancet Infect Dis 2008, 8:763-776.
14. Ranucci M., Isgrò G., Giomarelli P.P., et al. Impact of oligon central venous catheters on catheter colonization and catheter-related bloodstream infection. Crit Care Med 2003, 31:52-59.
15. Corral L., Nolla-Salas M., Ibañez-Nolla J., et al. A prospective, randomized study in critically ill patients using the Oligon Vantex catheter. J Hosp Infect 2003, 55:212-219.
16. Guggenbichler J.P., Böswald M., Lugauer S., Krall T. A new technology of microdispersed silver in polyurethane induces antimicrobial activity in central venous catheters. Infection 1999, 27(Suppl. 1):S16-S23.
17. Böswald M., Lugauer S., Regenfus A., et al. Reduced rates of catheter-associated infection by use of a new silver-impregnated central venous catheter. Infection 1999, 27(Suppl. 1):S56-S60.
18. Maki D.G., Weise C.E., Sarafin H.W. A semi quantitative culture method for identifying intravenous-catheter-related infection. N Engl J Med 1977, 296:1305-1309.
19. Ferreira F.L., Bota D.P., Bross A., Mélot C., Vincent J.L. Serial evaluation of the SOFA score to predict outcome in critically ill patients. JAMA 2001, 286:1754-1758.
20. Le Gall J.R., Lemeshow S., Saulnier F. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 1993, 270:2957-2963.
21. Maki D.G., Stolz S.M., Wheeler S., Mermel L.A. Prevention of central venous catheter-related bloodstream infection by use of an antiseptic-impregnated catheter. A randomized, controlled trial. Ann Intern Med 1997, 127:257-266.
22. Raad I., Darouiche R., Dupuis J. Central venous catheters coated with minocycline and rifampin for the prevention of catheter-related colonization and bloodstream infections. A randomized, double-blind trial. The Texas Medical Center Catheter Study Group. Ann Intern Med 1997, 127:267-274.
23. Darouiche R.O., Raad I.I., Heard S.O., et al. A comparison of two antimicrobial-impregnated central venous catheters. Catheter Study Group. N Engl J Med 1999, 340:1-8.
24. Gilbert R.E., Harden M. Effectiveness of impregnated central venous catheters for catheter related blood stream infection: a systematic review. Curr Opin Infect Dis 2008, 21:235-245.
25. Bach A., Eberhardt H., Frick A., Schmidt H., Böttiger B.W., Martin E. Efficacy of silver-coating central venous catheters in reducing bacterial colonization. Crit Care Med 1999, 27:515-521.
26. Dünser M.W., Mayr A.J., Hinterberger G., et al. Central venous catheter colonization in critically ill patients: a prospective, randomized, controlled study comparing standard with two antiseptic-impregnated catheters. Anesth Analg 2005, 101:1778-1784.
27. Moretti E.W., Ofstead C.L., Kristy R.M., Wetzler H.P. Impact of central venous catheter type and methods on catheter-related colonization and bacteraemia. J Hosp Infect 2005, 61:139-145.
28. Fraenkel D., Rickard C., Thomas P., Faoagali J., George N., Ware R. A prospective, randomized trial of rifampicin-minocycline-coated and silver-platinum-carbon-impregnated central venous catheters. Crit Care Med 2006, 34:668-675.
29. Kalfon P., de Vaumas C., Samba D., et al. Comparison of silver-impregnated with standard multi-lumen central venous catheters in critically ill patients. Crit Care Med 2007, 35:1032-1039.
30. Khare M.D., Bukhari S.S., Swann A., Spiers P., McLaren I., Myers J. Reduction of catheter-related colonisation by the use of a silver zeolite-impregnated central vascular catheter in adult critical care. J Infect 2007, 54:146-150.
31. Rijnders B.J., Van Wijngaerden E., Peetermans W.E. Catheter-tip colonization as a surrogate end point in clinical studies on catheter-related bloodstream infection: how strong is the evidence?. Clin Infect Dis 2002, 35:1053-1058.
32. Schierholz J.M., Bach A., Fleck C., Beuth J., König D., Pulverer G. Measurement of ultrasonic-induced chlorhexidine liberation: correlation of the activity of chlorhexidine-silver-sulfadiazine-impregnated catheters to agar roll technique and broth culture. J Hosp Infect 2000, 44:141-145.
33. Schmitt S.K., Knapp C., Hall G.S., Longworth D.L., McMahon J.T., Washington J.A. Impact of chlorhexidine-silver sulfadiazine-impregnated central venous catheters on in vitro quantitation of catheter-associated bacteria. J Clin Microbiol 1996, 34:508-511.
34. Wang H., Huang T., Jing J., et al. Effectiveness of different central venous catheters for catheter-related infections: a network meta-analysis. J Hosp Infect 2010, 76:1-11.
35. Bjarnsholt T., Kirketerp-Møller K., Kristiansen S., et al. Silver against Pseudomonas aeruginosa biofilms. APMIS 2007, 115:921-928.
36. Pratt R.J., Pellowe C.M., Wilson J.A., et al. epic2: National evidence-based guidelines for preventing healthcare-associated infections in NHS hospitals in England. J Hosp Infect 2007, 65(Suppl. 1):S1-S64.